20 patients enrolled into SAFE-SSPE!

On March 25, 2021 the 20th patients was enrolled into SAFE-SSPE trial. Thank you all for your effort in screening and recruiting patients!

First patient enrolled in the Cantonal Hospital of Frauenfeld

We are happy to inform you that the first patient was enrolled in the Cantonal Hospital of Frauenfeld. Thank you for your effort in enrolling patients!

Principal investigator change at the hospital in Nyon

We are happy to inform you that Dr. Mallory Moret Bochatay has taken over the PI responsibility from Prof. T. Fumeaux at the Hospital of Nyon. Welcome to the SAFE-SSPE trial!

Hospital of Delémont open for accrual

We are happy to inform you that the Hospital of Delémont is now open for patient accrual. All planned 23 Swiss sites are now initiated and open for accrual. We wish the study team in Delémont good luck!

First patient enrolled at the University Hospital in Basel

First patient enrolled at the Triemli hospital in Zurich

We are happy to inform you that the first study participant was enrolled at the Triemli Hospital in Zurich today. We would like to thank the study team for the good collaboration

First patient enrolled in the Cantonal Hospital of St. Gallen

We are happy to inform you that the first patient was enrolled in the Cantonal Hospital of St. Gallen. Thank you for your effort!

Nine patients were enrolled so far into the SAFE-SSPE trial

We are happy to inform you that the second patient was enrolled in the Hospital of Bienne today. We thank the team for their effort!

Eight patients enrolled so far into the SAFE-SSPE trial

We are happy to inform you that the first patient was enrolled in the Hospital of Bienne today! In addition, the fifth patient was enrolled at the Inselspital also today.

The University Hospital of Geneva and the Hospital of Neuchâtel are open for patient enrollment.

As of today, the University Hospital of Geneva and the Hospital of Neuchâtel started with patient screening for the SAFE-SSPE study. Twenty-two Swiss trial sites are now open for accrual. We wish all the study teams good luck!